Atlas Trials

Efficacy of Lidocaine Versus Placebo in Palliative Care Patients With Opioid-refractory Cancer Pain With Neuropathic Component: a Multicenter, Prospective, Double-blind Randomized Placebo-controlled Study.

Clinical trial NCT02137954 · UNKNOWN

Trial details

NCT number
NCT02137954
Sponsor
Assistance Publique Hopitaux De Marseille
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
CancerPain With Neuropathic Component
Start date
2014-05-01
Primary completion
2016-06-01
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.